Last $0.0090 USD
Change Today 0.00 / 0.00%
Volume 0.0
ARYX On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 07/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Armen Tashjian Jr., M.D.

Former Member of Scientific Advisory Board, ARYx Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 4 different industries.

See Board Relationships
----

Background*

Armen H. Tashjian, Jr., M.D., Ph.D., serves as a Consultant to several pharmaceutical and biotechnology companies, and bioventure funds. Dr. Tashjian serves as Professor of Biological Chemistry, Molecular Pharmacology, Toxicology, Emeritus, in the Department of Cancer Cell Biology at the HSPH. Dr. Tashjian is the Deputy Editor of the recently published in 2004 textbook entitled Principles of Pharmacology: The Pathophysiological Basis of Drug Therapy. He also served as ...

Read Full Background

Corporate Headquarters*

6300 Dumbarton Circle
Fremont, California 94555

United States

Phone: 510-585-2200
Fax: 510-585-2202

Board Members Memberships*

Former Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARYX:US $0.01 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chief Executive Officer, Director, Member of Commercialization Committee and Member of Science & Technology Committee
Sucampo Pharmaceuticals, Inc.
--
Eduardo Javier Sanchiz Yrazu Chief Executive Officer, Member of Management Board, Chief Executive of Corporate Development & Finance, Executive Director and Member of Compliance Committee
Almirall, S.A.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARYX THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.